Though these findings indicate clinical significance of Gal-3 as a marker of breast malignancy, in vitro research using chemo-sensitive and resistant breast cancer cell lines will be necessary to validate these results for further translation into clinical practice. The gene discussed is LGALS3; the disease is breast carcinoma.